Dr. Stephen Ross

NYU School of Medicine, Lead Researcher in psilocybin treatment for end-of-life distress in patients with life-threatening cancer

Dr. Michael Bogenschutz

NYU School of Medicine, Leading Researcher in psilocybin treatments for addiction

Multidisciplinary Association for Psychedelic Studies (MAPS), Founder & Executive Director; Lead Researcher in MDMA treatment in PTSD patients

Dr. Rick Doblin

The scientific research is led by:

Meet The Team

Fund a Mental Health Revolution

people around the world are suffering from mental health issues.

450 million

At Fundamental  we do not support or foment use of psychedelics or any other types of drugs for recreational use. The purpose of this initiative is to garner funds and support exclusively for rigorous scientific research of psychedelics for therapeutic purposes and other applications. The studies yield results relating to the use of psychedelic compounds exclusively under controlled environments under the supervision of trained professionals. Under no circumstances should anyone prone to or suffering from schizophrenia and/or bipolar disorder intake any psychedelic compounds.

FUNDAMENTAL invites you to spark a mental health revolution by donating to a crowdfunding campaign focused on the development of groundbreaking research. All donations will fund studies on psychedelic science, led by highly reputable institutions around the world.

Learn more about what the media is saying

This means that one in four Americans currently struggle with mental health, leading to over USD $400 billion in lost earnings and health care costs each year. About two thirds of those diagnosed never seek treatment.

Mental illness affects everyone—from cancer patients struggling with end-of-life distress, to veterans suffering from PTSD. In the US, suicide is the 10th leading cause of death, and 90% of individuals who die by suicide experience mental illness.

What if you had the power to do something about this alarming reality?

people struggle with mental health

60 million

In the US alone,

Prevalence of mental illness by diagnosis*

42 Million Adults 

16 Million Adults 

17 Million Adults 

*Based on 2015 reports by the National Alliance on Mental Illness and 2012 reports by the National Institute on Alcohol Abuse and Alcoholism

Anxiety Disorders

Major Depression

Alcohol Abuse Disorder

An important part of the problem is that medicine today continues to treat symptoms and not the root causes

Current available solutions typically involve a combination of psychotherapy and pharmacotherapy. The effects vary from individual to individual, making it very difficult to gage what the current treatments actually do for patients.
Until now, mental health has largely been managed through traditional methods of treatment, which in many cases come with a raft of problems: treatments are expensive, bear unpleasant side effects, vary in their consistency, offer no specific completion date, and only treat the symptoms of these illnesses as opposed to the root cause.

New studies offer promising relief for a variety of mood-altering illnesses, through an unlikely source. A group of scientists at prestigious research institutions - NYU, Johns Hopkins, MAPS and the Imperial College of London - are conducting studies with psilocybin, MDMA and LSD  to treat end-of-life distress, alcohol and drug addiction, PTSD, and find new applications for mental health.

So far the results are very promising, creating an opportunity for these groundbreaking treatments to be medicalized.

Currently the research depends on the support of a few private donors and institutions, with no help from governments or pharmaceutical companies.

These government approved clinical trials must receive continuous funding to go through the process towards medicalization and re-scheduling of the compounds.

By crowdfunding scientific research, the friends and family of those affected by mental health finally have the opportunity to directly contribute to a solution.

The Opportunity

The Beckley Foundation, Founder & director
Imperial Research Programme, Co-director, leading research in Microdosing with LSD focused on cognition & creativity

Amanda Feilding

The mystical experience is composed of six main parts

According to Dr. Walter Pahnke and Dr. William Richards:

Since traditional sources of funding are limited, Fundamental is crowdfunding to support scientific research for the application of psychedelic compounds as therapeutic treatments. 


© Copyright 2017 Fundamental


Testimonial: The experience did not restore him to his former life, he said, “but I have a greater sense of peace of what might come. I’m very grateful, beyond words, for this trial. But you have to approach the session with the right intentions of why you’re doing it. Because you’re going to meet yourself. ”

Mystical-type experiences induced by psychedelics predict long term positive changes in attitudes, mood, behavior and spirituality in patients.

Ineffability and Paradoxicality

Internal Unity

Trascendence of Time and Space

Deeply-Felt Positive Mood

Sense of Sacredness

A sense that the experience cannot be described adequately in words. An experience of a paradoxical awareness that two apparently opposite principles or situations are both true.

Freedom from the limitations of one’s personal self and feeling a unity or bond with what was felt to be greater than one’s personal self. An experience of the insight that “all is One.”

A feeling that the consciousness experienced during part of the session was more real than one’s normal awareness of everyday reality; realizing a truth that is greater than the truth.

A feeling that one experienced something profoundly sacred and holy; a sense of awe or awesomeness; a sense of the limitations and smallness of one’s everyday personality in contrast to the Infinite.

An experience of overflowing energy, feelings of peace and tranquility, universal or infinite love,  and absolute ecstasy.

A feeling of experiencing eternity or infinity; a loss of the usual sense of time and space; a feeling that one has been outside of history in a realm where time does not exist.





Noetic Quality



How It Works

and institutions actively fundraise on CrowdRise

All funds go into FUNDAMENTAL's Donor Advised Fund.

Each tax-deductible donation will be deposited in a Donor Advised Fund, held at CAFA, to ensure transparency and security for each donor




Funds are distributed as grants to the different research programs

Once the crowdfunding campaign is closed, the DAF will grant the funds to approved institutions with the exclusive purpose of supporting the research.

End-of-Life Distress research

Alcoholism research

PTSD research

Micro-dosing research

Pharmaceutical companies are not typically interested in psychedelics due to the misalignment between profit and impact—and though government entities have granted licenses to legally study the compounds—no funding has yet been provided. Due to the socio-political stigma of psychedelic compounds, and their classification as Schedule 1 substances, support for this research is critical.

Now suppose you could be a part of it. That it is in your hands to spark a mental health revolution in the name of someone you love.

You would contribute in any way you could, wouldn’t you?

A New Perspective

Today, traditional sources of funding are lacking in support of this research.

Contact Us: info@fundamental.nyc

The Alternative Approach


The Problematic

It is time to make a conscious impact. 

The Fundamental Approach